Jim Cramer noted that Teva Pharmaceuticals (TEVA)  cut their dividend and they're talking about pressure in U.S. generics. That's pretty interesting because that's the business that they bought from Allergan (AGN) . People just feel like it doesn't have the oomph but they did boost the forecast. 

Jim Cramer also noted that Teva is probably the weakest of the pharmaceuticals group.  

Watch all of Jim Cramer's latest videos, right here:

More from Video

Everything You Need to Know About Closed-End Funds to Boost Your Portfolio

Everything You Need to Know About Closed-End Funds to Boost Your Portfolio

Sears CEO Eddie Lampert's Latest Idea to Save Dying Retailer Hints End Nearing

Sears CEO Eddie Lampert's Latest Idea to Save Dying Retailer Hints End Nearing

60 Seconds: What Is a Closed-End Fund?

60 Seconds: What Is a Closed-End Fund?

Micron's Weak Quarterly Guidance: How Worried Should Investors Be?

Micron's Weak Quarterly Guidance: How Worried Should Investors Be?

NYSE Trader on Sirius, Pandora and Monday's Stock Market Decline

NYSE Trader on Sirius, Pandora and Monday's Stock Market Decline